好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Therapy of Neuromuscular Disease

Sunday 04/17/16
06:30 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Michael D. Weiss, MD, FAAN
Participants should be familiar with the current management of ALS, inflammatory neuropathies and myopathies, and myasthenia gravis.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Trainee, General Neurologist, Specialist Neurologist
Didactic
Event Timeline
06:30 AM - 06:55 AM Treatment of Amyotrophic Lateral Sclerosis
Michael D. Weiss, MD, FAAN
06:55 AM - 07:00 AM Questions and Answers
Michael D. Weiss, MD, FAAN
07:00 AM - 07:25 AM Treatment of Inflammatory Neuropathies
Michael D. Weiss, MD, FAAN
07:25 AM - 07:30 AM Questions and Answers
Michael D. Weiss, MD, FAAN
07:30 AM - 07:55 AM Treatment of Myasthenia Gravis
Anthony A. Amato, MD, FAAN
07:55 AM - 08:00 AM Questions and Answers
Anthony A. Amato, MD, FAAN
08:00 AM - 08:25 AM Treatment of Inflammatory Myopathies
Anthony A. Amato, MD, FAAN
08:25 AM - 08:30 AM Questions and Answers
Anthony A. Amato, MD, FAAN
Faculty Disclosures
Anthony A. Amato, MD, FAAN Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abscuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.
Michael D. Weiss, MD, FAAN Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.